Skip to main content
. 2003 Jul 29;89(3):585–592. doi: 10.1038/sj.bjc.6601131

Figure 3.

Figure 3

Impact of ZD1839 on key pathways regulated by EGFR signalling. (A) ZD1839 (6 μM, IC50 value) diminished MAP kinase phosphorylation. (B) ZD1839 (6 μM, IC50 value) diminished AKT phosphorylation. *P<0.05 vs control, bars indicate standard deviation from the mean of three separate experiments.